Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Dow
Express Scripts
Baxter
Colorcon

Last Updated: January 28, 2023

Taro Pharm Inds Ltd Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for TARO PHARM INDS LTD, and when can generic versions of TARO PHARM INDS LTD drugs launch?

TARO PHARM INDS LTD has twenty-six approved drugs.

There are two US patents protecting TARO PHARM INDS LTD drugs. There are three tentative approvals on TARO PHARM INDS LTD drugs.

There are nine patent family members on TARO PHARM INDS LTD drugs in six countries and twenty-three supplementary protection certificates in twelve countries.

Summary for Taro Pharm Inds Ltd
International Patents:9
US Patents:2
Tradenames:18
Ingredients:16
NDAs:26

Drugs and US Patents for Taro Pharm Inds Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm Inds Ltd OVIDE malathion LOTION;TOPICAL 018613-001 Aug 2, 1982 DISCN Yes No 7,560,445 See Plans and Pricing Y Y See Plans and Pricing
Taro Pharm Inds Ltd DOXEPIN HYDROCHLORIDE doxepin hydrochloride CAPSULE;ORAL 213063-003 Jul 1, 2020 AB RX No No See Plans and Pricing See Plans and Pricing
Taro Pharm Inds Ltd ACETAMINOPHEN acetaminophen SUPPOSITORY;RECTAL 018337-002 Approved Prior to Jan 1, 1982 OTC Yes No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for TARO PHARM INDS LTD drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Spray 0.25% ➤ Subscribe 2013-12-18
➤ Subscribe Topical Lotion 0.5% ➤ Subscribe 2011-03-16

Supplementary Protection Certificates for Taro Pharm Inds Ltd Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1304992 C01304992/01 Switzerland See Plans and Pricing PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
0809498 10C0038 France See Plans and Pricing PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
0152897 SPC/GB01/012 United Kingdom See Plans and Pricing PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
AstraZeneca
Johnson and Johnson
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.